Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Department of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Kidney Int. 2022 Dec;102(6):1331-1344. doi: 10.1016/j.kint.2022.07.035. Epub 2022 Sep 3.
Complement activation at a particular location is determined by the balance of activating and inhibitory proteins. Factor H is a key regulator of the alternative pathway of complement, and genetic or acquired impairments in Factor H are associated with glomerular injury. The human Factor H-related proteins (FHRs) comprise a family of five proteins that are structurally related to Factor H. Variations in the genes or expression levels of the FHRs are also associated with glomerular disease, although the mechanisms of glomerular protection/injury are incompletely understood. To explore the role of the FHRs on complement regulation/dysregulation in the kidney, we expressed and purified recombinant murine FHRs (FHRs A, B, C and E). These four distinct FHRs contain binding regions with high amino acid sequence homology to binding regions within Factor H, but we observed different interactions of the FHRs with Factor H binding ligands, including heparin and C3d. There was differential binding of the FHRs to the resident kidney cell types (mesangial, glomerular endothelial, podocytes, and tubular epithelial). All four FHRs caused complement dysregulation on kidney cell surfaces in vitro, although the magnitude of the effect differed among the FHRs and also varied among the different kidney cells. However, only FHR E caused glomerular complement dysregulation when injected in vivo but did not exacerbate injury when injected into mice with ischemic acute kidney injury, an alternative pathway-mediated model. Thus, our experiments demonstrate that the FHRs have unique, and likely context-dependent, effects on the different cell types within the kidney.
补体在特定位置的激活取决于激活和抑制蛋白的平衡。因子 H 是补体替代途径的关键调节剂,因子 H 的遗传或获得性缺陷与肾小球损伤有关。人类因子 H 相关蛋白 (FHRs) 由五个结构上与因子 H 相关的蛋白组成。FHRs 的基因或表达水平的变化也与肾小球疾病有关,尽管肾小球保护/损伤的机制尚不完全清楚。为了探讨 FHRs 在肾脏补体调节/失调中的作用,我们表达和纯化了重组鼠 FHRs(FHRs A、B、C 和 E)。这四种不同的 FHRs 包含与因子 H 结合区域具有高度氨基酸序列同源性的结合区域,但我们观察到 FHRs 与因子 H 结合配体(包括肝素和 C3d)的不同相互作用。FHRs 与驻留肾细胞类型(系膜细胞、肾小球内皮细胞、足细胞和肾小管上皮细胞)的结合存在差异。所有四种 FHRs 在体外均导致肾脏细胞表面补体失调,尽管 FHRs 之间的效应大小不同,而且在不同的肾脏细胞中也有所不同。然而,只有 FHR E 在体内注射时会引起肾小球补体失调,但在注射到缺血性急性肾损伤的小鼠(替代途径介导的模型)中时不会加重损伤。因此,我们的实验表明,FHRs 对肾脏内不同细胞类型具有独特的、可能依赖于背景的影响。